Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | CDC7 | O00311 | 2/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.33 |
| ▸ | DBF4 | Q9UBU7 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2996449 | 0.64 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL2998728 | 0.64 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL2998727 | 0.64 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL2996446 | 0.64 | CHRNB2 (0.36) | CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL15288771 | 0.62 | — | — | |
| SCHEMBL15288767 | 0.62 | — | — | |
| SCHEMBL298032 | 0.62 | — | — | |
| SCHEMBL11430461 | 0.60 | CHRNB2 (0.42) | CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL1889514 | 0.60 | CHRNB2 (0.65) | CHRNB2CHRNA7CHRNA4CYP2A6 | |
| SCHEMBL2335166 | 0.59 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1014974-B1 | TREATMENT OF SCHIZOPHRENIA AND PSYCHOSIS | LUNDBECK & CO AS H (DK) | 2004-08-11 | — | — | EP | disclosed |
| US-6297262-B1 | USE OF 5-(2-ETHYL-2H-TETRAZOL-5-YL)-1,2,3,6-TETRAHYDRO-1-METHYLPYRIDI NE | H. LUNDBECK A/S (DK) | 2001-10-02 | — | — | US | disclosed |
| WO-2001013918-A1 | TREATMENT OF URINARY INCONTINENCE | H. LUNDBECK A/S (DK) | 2001-03-01 | — | — | WO | disclosed |
| EP-1014974-A1 | TREATMENT OF SCHIZOPHRENIA AND PSYCHOSIS | H. LUNDBECK A/S (DK) | 2000-07-05 | — | — | EP | disclosed |
| WO-1998053820-A1 | TREATMENT OF SCHIZOPHRENIA AND PSYCHOSIS | H. LUNDBECK A/S (DK) | 1998-12-03 | — | — | WO | disclosed |
| EP-0866706-A1 | TREATMENT OF TRAUMATIC BRAIN INJURY | H. LUNDBECK A/S (DK) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997017074-A1 | TREATMENT OF TRAUMATIC BRAIN INJURY | H. LUNDBECK A/S (DK) | 1997-05-15 | — | — | WO | disclosed |